Literature DB >> 28585205

Adipose Tissue Hypoxia in Obesity and Its Impact on Preadipocytes and Macrophages: Hypoxia Hypothesis.

Atilla Engin1,2.   

Abstract

Obese subjects exhibit lower adipose tissue oxygen consumption in accordance with the lower adipose tissue blood flow. Thus, compared with lean subjects, obese subjects have 44% lower capillary density and 58% lower vascular endothelial growth factor (VEGF). The VEGF expression together with hypoxia-inducible transcription factor-1 (HIF-1) activity also requires phosphatidylinositol 3-kinase (PI3K)- and target of rapamycin (TOR)-mediated signaling. HIF-1alpha is an important signaling molecule for hypoxia to induce the inflammatory responses. Hypoxia affects a number of biological functions, such as angiogenesis, cell proliferation, apoptosis, inflammation and insulin resistance. Additionally, reactive oxygen radical (ROS) generation at mitochondria is responsible for propagation of the hypoxic signal. Actually mitochondrial ROS (mtROS) production, but not oxygen consumption is required for hypoxic HIF-1alpha protein stabilization. Adipocyte mitochondrial oxidative capacity is reduced in obese compared with non-obese adults. In this respect, mitochondrial dysfunction of adipocyte is associated with the overall adiposity. Furthermore, hypoxia also inhibits macrophage migration from the hypoxic adipose tissue. Alterations in oxygen availability of adipose tissue directly affect the macrophage polarization and are responsible from dysregulated adipocytokines production in obesity. Hypoxia also inhibits adipocyte differentiation from preadipocytes. In addition to stressed adipocytes, hypoxia contributes to immune cell immigration and activation which further aggravates adipose tissue fibrosis. Fibrosis is initiated in response to adipocyte hypertrophy in obesity.

Entities:  

Keywords:  Adipocyte differentiation; Adipose tissue blood flow; Angiogenesis; CAAT/enhancer binding protein (C/EBP); CAAT/enhancer binding protein (C/EBP)-homologous protein (CHOP); Hypoxia-inducible transcription factor-1 (HIF-1) alpha; Inducible nitric oxide synthase (iNOS); Mitochondrial ROS (mtROS); Obesity; Phosphatidylinositol 3-kinase (PI3K); Reactive oxygen species (ROS); Vascular endothelial growth factor (VEGF)

Mesh:

Year:  2017        PMID: 28585205     DOI: 10.1007/978-3-319-48382-5_13

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  38 in total

Review 1.  Adipocyte and lipid metabolism in cancer drug resistance.

Authors:  Yihai Cao
Journal:  J Clin Invest       Date:  2019-07-02       Impact factor: 14.808

2.  Obesity, sleep apnea, and cancer.

Authors:  Isaac Almendros; Miguel A Martinez-Garcia; Ramon Farré; David Gozal
Journal:  Int J Obes (Lond)       Date:  2020-02-18       Impact factor: 5.095

Review 3.  More than an Anti-diabetic Bariatric Surgery, Metabolic Surgery Alleviates Systemic and Local Inflammation in Obesity.

Authors:  Chunlan Zhang; Jingjing Zhang; Zhenqi Liu; Zhiguang Zhou
Journal:  Obes Surg       Date:  2018-11       Impact factor: 4.129

4.  Dark-Side of Exosomes.

Authors:  Atilla Engin
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

5.  Adipocyte-derived exosomes may promote breast cancer progression in type 2 diabetes.

Authors:  Naser Jafari; Manohar Kolla; Tova Meshulam; Jordan S Shafran; Yuhan Qiu; Allison N Casey; Isabella R Pompa; Christina S Ennis; Carla S Mazzeo; Nabil Rabhi; Stephen R Farmer; Gerald V Denis
Journal:  Sci Signal       Date:  2021-11-23       Impact factor: 8.192

Review 6.  Tumour fatty acid metabolism in the context of therapy resistance and obesity.

Authors:  Andrew J Hoy; Shilpa R Nagarajan; Lisa M Butler
Journal:  Nat Rev Cancer       Date:  2021-08-20       Impact factor: 60.716

Review 7.  Intermittent Fasting: Potential Utility in the Treatment of Chronic Pain across the Clinical Spectrum.

Authors:  Jesse P Caron; Margaret Ann Kreher; Angela M Mickle; Stanley Wu; Rene Przkora; Irene M Estores; Kimberly T Sibille
Journal:  Nutrients       Date:  2022-06-18       Impact factor: 6.706

Review 8.  Obesity: a neuroimmunometabolic perspective.

Authors:  Chelsea M Larabee; Oliver C Neely; Ana I Domingos
Journal:  Nat Rev Endocrinol       Date:  2019-11-27       Impact factor: 43.330

Review 9.  Innate Immune Cells in the Adipose Tissue in Health and Metabolic Disease.

Authors:  Zoi Michailidou; Mario Gomez-Salazar; Vasileia Ismini Alexaki
Journal:  J Innate Immun       Date:  2021-04-13       Impact factor: 7.349

Review 10.  Obesity and Androgen Receptor Signaling: Associations and Potential Crosstalk in Breast Cancer Cells.

Authors:  Nelson Rangel; Victoria E Villegas; Milena Rondón-Lagos
Journal:  Cancers (Basel)       Date:  2021-05-06       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.